• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/22/2020
Event Type  Injury  
Event Description
Covid 19 [covid-19]. Synvisc medication is ineffective [device ineffective]. Case narrative: initial information received on (b)(6) 2021 regarding an unsolicited valid serious case received from patient via health authorities (mw5098329) from united states. This case involves an adult male patient who experienced covid 19 and synvisc medication was ineffective, while he was using the medical device hylan g-f 20, sodium hyaluronate (synvisc). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started using hylan g-f 20, sodium hyaluronate (formulation, strength, dose, frequency, route, batch number: unknown) for unilateral primary osteoarthritis right knee. There will be no information available for batch number of this case. On (b)(6) 2020, after unknown latency, patient was diagnosed with covid-19 due to which he was hospitalized in 2020. On an unknown date in 2020, patient was discharged. It was reported that his hylan g-f 20, sodium hyaluronate medication was ineffective (device ineffective; onset date and latency: unknown) so his doctor would be prescribing him a new therapy. Final diagnosis was covid 19 and synvisc medication is ineffective. Action taken: not applicable for device ineffective and unknown for covid-19. It was not reported if the patient received a corrective treatment for both events outcome: unknown for covid 19 and not applicable for synvisc medication is ineffective. Seriousness criteria: hospitalization. A product technical complaint (ptc) was initiated on 04-feb-2021 for synvisc. Batch number: unknown; comet compliant id number: (b)(4). The product lot number was not provided; therefore, a batch record review was not possible. Based on the lack of information provided, no capa was required. It was the requirement to review all finished batch records for specification conformance prior to release. Any out of specification result is identified and mitigated through the ncr process. Sanofi global pharmacovigilance and epidemiology continuously monitors adverse event reports with or without lot numbers, and assesses possible associations with their corresponding product lot, as part of routine safety surveillance effort to detect safety signals. This review has not indicated any safety issue. Final investigation complete date was 10-feb-2021. No safety issues were indicated in this review. Additional information was received on 10-feb-2021 from the other healthcare professional. Global ptc number and ptc results were added. Clinical course updated and text amended accordingly.
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of DeviceMOZ
Manufacturer (Section D)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
bridgewater 08807
MDR Report Key11336724
MDR Text Key240794616
Report Number2246315-2021-00070
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 06/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 02/17/2021 Patient Sequence Number: 1